MBOT
Microbot Medical Inc.
Price Chart
Latest Quote
$1.79
-0.03 (-1.65%)
Current Price
| Previous Close | $1.82 |
| Open | $1.82 |
| Day High | $1.83 |
| Day Low | $1.77 |
| Volume | 501,896 |
Stock Information
| Shares Outstanding | 67.16M |
| Total Debt | $898K |
| Cash Equivalents | $72.50M |
| Revenue | $105K |
| Net Income | $-14.21M |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Market Cap | $120.22M |
| EPS (TTM) | $-0.26 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $48.62M |
| Sales | $105K |
| Income | $-14.21M |
| Book/sh | $1.10 |
| Cash/sh | $1.08 |
| Employees | 43 |
Financial Ratios
| Quick Ratio | 21.44 |
| Current Ratio | 22.59 |
| Debt/Eq | 1.21 |
Returns & Margins
| ROA | -18.40% |
| ROE | -27.58% |
| Gross Margin | 1.91% |
| Operating Margin | -4114.29% |
Ownership
| Institutional Ownership | 21.76% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -5.59 |
| PEG | 0.70 |
| P/S | 1145.00 |
| P/B | 1.62 |
Analyst Data
| Recommendation | none |
| Target Price | $7.00 |
Technical Indicators
| SMA20 | $1.86 |
| SMA50 | $2.00 |
| SMA200 | $2.33 |
| RSI | 31.25 |
| ATR | 0.0893 |
| Shares Float | 67.16M |
| Short Float | 11.40% |
| Short Ratio | 3.86 |
| Rel Volume | 0.41 |
Performance History
| Week | -1.65% |
| Month | +4.68% |
| Quarter | -28.40% |
| 6 Months | -13.94% |
| YTD | -15.17% |
| Year | -24.15% |
| 3 Years | -41.69% |
| 5 Years | -76.75% |
| 10 Years | -96.42% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-24 | $1.79 | 508,800 |
| 2026-06-23 | $1.82 | 894,400 |
| 2026-06-22 | $1.85 | 1,117,200 |
| 2026-06-18 | $1.86 | 1,061,500 |
| 2026-06-17 | $1.88 | 743,700 |
| 2026-06-16 | $1.82 | 872,300 |
| 2026-06-15 | $1.82 | 802,000 |
| 2026-06-12 | $1.78 | 920,000 |
| 2026-06-11 | $1.82 | 603,800 |
| 2026-06-10 | $1.77 | 581,700 |
| 2026-06-09 | $1.82 | 1,261,600 |
| 2026-06-08 | $1.82 | 826,800 |
| 2026-06-05 | $1.84 | 877,400 |
| 2026-06-04 | $1.96 | 973,800 |
| 2026-06-03 | $1.97 | 1,200,700 |
| 2026-06-02 | $2.01 | 1,255,300 |
| 2026-06-01 | $1.98 | 1,518,600 |
| 2026-05-29 | $2.03 | 3,631,900 |
| 2026-05-28 | $1.93 | 3,851,800 |
| 2026-05-27 | $1.71 | 1,283,000 |
| 2026-05-26 | $1.81 | 2,335,500 |
About Microbot Medical Inc.
Microbot Medical Inc. is a medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system designed to maneuver guidewires and over-the-wire devices such as microcatheters within the body's vasculature for use in cardiovascular, peripheral, endovascular, and neurovascular operations. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a collaboration agreement with Corewell Health for the development of LIBERTY endovascular robotic system; and Emory University, in connection with autonomous robotics in endovascular procedures. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts
đ° Latest News
After Plunging 22.6% in 4 Weeks, Here's Why the Trend Might Reverse for Microbot Medical (MBOT)
Zacks âĸ 2026-05-19T13:35:02Z
Microbot Medical (NASDAQ:MBOT) Is In A Good Position To Deliver On Growth Plans
Simply Wall St. âĸ 2026-05-16T13:24:00Z
Microbot Medical Inc. (MBOT) Reports Q1 Loss, Misses Revenue Estimates
Zacks âĸ 2026-05-13T22:40:01Z
DENTSPLY SIRONA to Post Q1 Earnings: What's in Store for the Stock?
Zacks âĸ 2026-05-04T17:39:00Z
Can Strong Growth Aid INNV's Q3 Earnings Amid Margin Seasonality?
Zacks âĸ 2026-05-04T12:54:00Z
Will DXCM's G7 Uptake Continue to Drive Top-line Growth in Q1?
Zacks âĸ 2026-04-24T18:20:00Z
Microbot Medical Begins Full U.S. Launch of LIBERTY System
Zacks âĸ 2026-04-15T16:32:00Z
Here's Why We're Not Too Worried About Microbot Medical's (NASDAQ:MBOT) Cash Burn Situation
Simply Wall St. âĸ 2025-12-07T13:07:24Z
Sector Update: Health Care Stocks Softer Late Afternoon
MT Newswires âĸ 2025-11-26T20:51:56ZSector Update: Health Care Stocks Mixed in Afternoon Trading
MT Newswires âĸ 2025-11-26T18:51:02Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Total Revenue | $0 | $0 | $0 | $0 |
| Operating Revenue | $0 | $0 | $0 | $0 |
| Expenses | ||||
| Total Expenses | $14,743,000 | $11,625,000 | $10,136,000 | $13,437,000 |
| Other Income Expense | $316,000 | - | $-832,000 | $215,000 |
| Other Non Operating Income Expenses | $316,000 | - | - | - |
| Net Non Operating Interest Income Expense | $1,285,000 | $182,000 | $228,000 | $54,000 |
| Total Other Finance Cost | $-1,285,000 | $-182,000 | $-228,000 | - |
| Operating Expense | $14,743,000 | $11,625,000 | $10,136,000 | $13,437,000 |
| Other Operating Expenses | $213,000 | $74,000 | $95,000 | $120,000 |
| General And Administrative Expense | $8,247,000 | $4,921,000 | $4,317,000 | $5,581,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-13,142,000 | $-11,443,000 | $-10,740,000 | $-13,168,000 |
| Net Interest Income | $1,285,000 | $182,000 | $228,000 | $54,000 |
| Normalized Income | $-13,142,000 | $-11,443,000 | $-9,908,000 | $-13,383,000 |
| Net Income From Continuing And Discontinued Operation | $-13,142,000 | $-11,443,000 | $-10,740,000 | $-13,168,000 |
| Total Operating Income As Reported | $-14,743,000 | $-11,625,000 | $-9,855,000 | $-13,281,000 |
| Net Income Common Stockholders | $-13,142,000 | $-11,443,000 | $-10,740,000 | $-13,168,000 |
| Net Income | $-13,142,000 | $-11,443,000 | $-10,740,000 | $-13,168,000 |
| Net Income Including Noncontrolling Interests | $-13,142,000 | $-11,443,000 | $-10,740,000 | $-13,168,000 |
| Net Income Continuous Operations | $-13,142,000 | $-11,443,000 | $-10,740,000 | $-13,168,000 |
| Pretax Income | $-13,142,000 | $-11,443,000 | $-10,740,000 | $-13,168,000 |
| Operating Income | $-14,743,000 | $-11,625,000 | $-10,136,000 | $-13,437,000 |
| Special Income Charges | - | $0 | $-832,000 | $151,000 |
| Interest Income | - | - | $283,000 | $54,000 |
| Interest Income Non Operating | - | - | $283,000 | $54,000 |
| Depreciation Amortization Depletion Income Statement | - | - | - | - |
| Depreciation And Amortization In Income Statement | - | - | - | - |
| Depreciation Income Statement | - | - | - | - |
| Per Share | ||||
| Diluted EPS | $-0.29 | $-0.73 | $-1.05 | $-1.81 |
| Basic EPS | $-0.29 | $-0.73 | $-1.05 | $-1.81 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-14,696,000 | $-11,534,000 | $-9,198,000 | $-13,550,000 |
| Reconciled Depreciation | $47,000 | $91,000 | $106,000 | $102,000 |
| EBITDA (Bullshit earnings) | $-14,696,000 | $-11,534,000 | $-10,030,000 | $-13,335,000 |
| EBIT | $-14,743,000 | $-11,625,000 | $-10,136,000 | $-13,437,000 |
| Diluted Average Shares | $45,790,362 | $15,644,511 | $10,199,984 | $7,260,344 |
| Basic Average Shares | $45,790,362 | $15,644,511 | $10,199,984 | $7,260,344 |
| Diluted NI Availto Com Stockholders | $-13,142,000 | $-11,443,000 | $-10,740,000 | $-13,168,000 |
| Research And Development | $6,283,000 | $6,630,000 | $5,724,000 | $7,736,000 |
| Selling General And Administration | $8,247,000 | $4,921,000 | $4,317,000 | $5,581,000 |
| Other Gand A | $3,280,000 | $1,428,000 | $1,664,000 | $1,670,000 |
| Insurance And Claims | $393,000 | $442,000 | $442,000 | $733,000 |
| Salaries And Wages | $4,574,000 | $3,051,000 | $2,211,000 | $3,178,000 |
| Total Unusual Items | - | $0 | $-832,000 | $215,000 |
| Total Unusual Items Excluding Goodwill | - | $0 | $-832,000 | $215,000 |
| Gain On Sale Of Ppe | - | $0 | $-2,000 | $-5,000 |
| Other Special Charges | - | - | $830,000 | $-156,000 |
| Gain On Sale Of Security | - | - | $-55,000 | $64,000 |
| Restructuring And Mergern Acquisition | - | - | - | - |
Fetched: 2026-06-23
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $77,554,000 | $3,530,000 | $4,501,000 | $7,289,000 |
| Total Assets | $81,544,000 | $6,031,000 | $8,327,000 | $9,537,000 |
| Total Non Current Assets | $1,722,000 | $212,000 | $406,000 | $723,000 |
| Other Non Current Assets | $59,000 | - | - | - |
| Non Current Prepaid Assets | $737,000 | $0 | - | - |
| Current Assets | $79,822,000 | $5,819,000 | $7,921,000 | $8,814,000 |
| Restricted Cash | $2,000 | $49,000 | $49,000 | $77,000 |
| Inventory | $584,000 | $0 | - | - |
| Receivables | $644,000 | $300,000 | $1,487,000 | $532,000 |
| Other Receivables | $644,000 | $300,000 | $1,487,000 | $532,000 |
| Cash Cash Equivalents And Short Term Investments | $78,592,000 | $5,470,000 | $6,385,000 | $8,205,000 |
| Cash And Cash Equivalents | $3,912,000 | $3,114,000 | $2,468,000 | $2,442,000 |
| Cash Financial | $3,912,000 | $3,114,000 | $2,468,000 | $1,195,000 |
| Cash Equivalents | - | - | $0 | $1,247,000 |
| Prepaid Assets | - | - | - | $429,000 |
| Loans Receivable | - | - | - | - |
| Debt | ||||
| Total Debt | $865,000 | $111,000 | $231,000 | $462,000 |
| Long Term Debt And Capital Lease Obligation | $569,000 | $41,000 | $40,000 | $179,000 |
| Current Debt And Capital Lease Obligation | $296,000 | $70,000 | $191,000 | $283,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $3,990,000 | $2,501,000 | $3,826,000 | $2,248,000 |
| Total Non Current Liabilities Net Minority Interest | $569,000 | $41,000 | $40,000 | $179,000 |
| Current Liabilities | $3,421,000 | $2,460,000 | $3,786,000 | $2,069,000 |
| Other Current Liabilities | $5,000 | $5,000 | $79,000 | $298,000 |
| Current Deferred Liabilities | $93,000 | $0 | - | - |
| Payables And Accrued Expenses | $1,048,000 | $976,000 | $2,791,000 | $116,000 |
| Payables | $511,000 | $165,000 | $357,000 | $116,000 |
| Accounts Payable | $511,000 | $165,000 | $357,000 | $116,000 |
| Equity | ||||
| Common Stock Equity | $77,554,000 | $3,530,000 | $4,501,000 | $7,289,000 |
| Total Equity Gross Minority Interest | $77,554,000 | $3,530,000 | $4,501,000 | $7,289,000 |
| Stockholders Equity | $77,554,000 | $3,530,000 | $4,501,000 | $7,289,000 |
| Retained Earnings | $-104,086,000 | $-90,944,000 | $-79,501,000 | $-68,761,000 |
| Other | ||||
| Ordinary Shares Number | $67,158,044 | $19,399,513 | $11,707,317 | $7,890,628 |
| Share Issued | $67,158,044 | $19,399,513 | $11,707,317 | $7,890,628 |
| Tangible Book Value | $77,554,000 | $3,530,000 | $4,501,000 | $7,289,000 |
| Invested Capital | $77,554,000 | $3,530,000 | $4,501,000 | $7,289,000 |
| Working Capital | $76,401,000 | $3,359,000 | $4,135,000 | $6,745,000 |
| Capital Lease Obligations | $865,000 | $111,000 | $231,000 | $462,000 |
| Total Capitalization | $77,554,000 | $3,530,000 | $4,501,000 | $7,289,000 |
| Additional Paid In Capital | $180,968,000 | $94,279,000 | $83,884,000 | $75,970,000 |
| Capital Stock | $672,000 | $195,000 | $118,000 | $80,000 |
| Common Stock | $672,000 | $195,000 | $118,000 | $80,000 |
| Long Term Capital Lease Obligation | $569,000 | $41,000 | $40,000 | $179,000 |
| Current Deferred Revenue | $93,000 | $0 | - | - |
| Current Capital Lease Obligation | $296,000 | $70,000 | $191,000 | $283,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $1,979,000 | $1,409,000 | $725,000 | $1,372,000 |
| Current Accrued Expenses | $537,000 | $811,000 | $2,434,000 | $0 |
| Net PPE | $926,000 | $212,000 | $406,000 | $723,000 |
| Accumulated Depreciation | $-631,000 | $-584,000 | $-493,000 | $-387,000 |
| Gross PPE | $1,557,000 | $796,000 | $899,000 | $1,110,000 |
| Leases | $229,000 | $229,000 | $229,000 | $229,000 |
| Other Properties | $833,000 | $132,000 | - | $502,000 |
| Machinery Furniture Equipment | $495,000 | $435,000 | $410,000 | $379,000 |
| Properties | $0 | $0 | $0 | $0 |
| Work In Process | $168,000 | $0 | - | - |
| Raw Materials | $416,000 | $0 | - | - |
| Other Short Term Investments | $74,680,000 | $2,356,000 | $3,917,000 | $5,763,000 |
| Buildings And Improvements | - | $132,000 | $260,000 | $502,000 |
| Treasury Shares Number | - | - | $0 | - |
Fetched: 2026-06-23
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-13,106,000 | $-8,852,000 | $-8,566,000 | $-11,633,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-13,046,000 | $-8,827,000 | $-8,533,000 | $-11,549,000 |
| Cash Flow From Continuing Operating Activities | $-13,046,000 | $-8,827,000 | $-8,533,000 | $-11,549,000 |
| Operating Gains Losses | - | - | $2,000 | $5,000 |
| Investing Activities | ||||
| Capital Expenditure | $-60,000 | $-25,000 | $-33,000 | $-84,000 |
| Investing Cash Flow | $-72,384,000 | $1,537,000 | $1,973,000 | $-3,836,000 |
| Cash Flow From Continuing Investing Activities | $-72,384,000 | $1,537,000 | $1,973,000 | $-3,836,000 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $86,239,000 | $7,936,000 | $6,558,000 | $4,324,000 |
| Financing Cash Flow | $86,240,000 | $7,936,000 | $6,558,000 | $4,324,000 |
| Cash Flow From Continuing Financing Activities | $86,240,000 | $7,936,000 | $6,558,000 | $4,324,000 |
| Net Common Stock Issuance | $86,239,000 | $7,936,000 | $6,558,000 | $4,324,000 |
| Common Stock Issuance | $86,239,000 | $7,936,000 | $6,558,000 | $4,324,000 |
| Other | ||||
| End Cash Position | $3,973,000 | $3,163,000 | $2,517,000 | $2,519,000 |
| Beginning Cash Position | $3,163,000 | $2,517,000 | $2,519,000 | $13,580,000 |
| Changes In Cash | $810,000 | $646,000 | $-2,000 | $-11,061,000 |
| Proceeds From Stock Option Exercised | $1,000 | $0 | - | - |
| Net Investment Purchase And Sale | $-72,324,000 | $1,562,000 | $2,006,000 | $-3,752,000 |
| Sale Of Investment | $10,602,000 | $6,682,000 | $12,066,000 | $0 |
| Purchase Of Investment | $-82,926,000 | $-5,120,000 | $-10,060,000 | $-3,752,000 |
| Net PPE Purchase And Sale | $-60,000 | $-25,000 | $-33,000 | $-84,000 |
| Purchase Of PPE | $-60,000 | $-25,000 | $-33,000 | $-84,000 |
| Change In Working Capital | $-1,008,000 | $942,000 | $-11,000 | $-228,000 |
| Change In Payables And Accrued Expense | $495,000 | $873,000 | $-683,000 | $-241,000 |
| Change In Prepaid Assets | $-919,000 | $69,000 | $672,000 | $13,000 |
| Change In Inventory | $-584,000 | $0 | - | - |
| Stock Based Compensation | $1,057,000 | $1,349,000 | $1,394,000 | $1,752,000 |
| Depreciation Amortization Depletion | $47,000 | $91,000 | $106,000 | $102,000 |
| Depreciation And Amortization | $47,000 | $91,000 | $106,000 | $102,000 |
| Depreciation | $47,000 | $91,000 | $106,000 | $102,000 |
| Net Income From Continuing Operations | $-13,142,000 | $-11,443,000 | $-10,740,000 | $-13,168,000 |
| Other Non Cash Items | - | $234,000 | $716,000 | $-12,000 |
| Gain Loss On Sale Of PPE | - | $0 | $2,000 | $5,000 |
| Unrealized Gain Loss On Investment Securities | - | - | - | $-12,000 |
| Interest Paid Supplemental Data | - | - | - | - |
Fetched: 2026-06-23